149 related articles for article (PubMed ID: 1382342)
1. Antibody response to human papovavirus JC (JCV) and simian virus 40 (SV40) T antigens in SV40 T antigen-transgenic mice.
Tevethia SS; Epler M; Georgoff I; Teresky A; Marlow M; Levine AJ
Virology; 1992 Sep; 190(1):459-64. PubMed ID: 1382342
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte recognition sequences as markers for distinguishing among tumour antigens encoded by SV40, BKV and JCV.
Tevethia SS; Mylin L; Newmaster R; Epler M; Lednicky JA; Butel JS; Tevethia MJ
Dev Biol Stand; 1998; 94():329-39. PubMed ID: 9776254
[TBL] [Abstract][Full Text] [Related]
3. Localization of common cytotoxic T lymphocyte recognition epitopes on simian papovavirus SV40 and human papovavirus JC virus T antigens.
Deckhut AM; Tevethia MJ; Haggerty S; Frisque RJ; Tevethia SS
Virology; 1991 Jul; 183(1):122-32. PubMed ID: 1711255
[TBL] [Abstract][Full Text] [Related]
4. PAb1614, a monoclonal antibody reactive with the tumor antigens of SV40, JC, BK, and polyoma virus, and other JC virus tumor antigen cross-reactive antibodies of the PAb1601-1636 panel.
Hess R; Oberbeck J; Grussenmeyer T; Schoeffel-Keller A; Haessler C; Braun DG; Brandner G
Intervirology; 1994; 37(1):47-52. PubMed ID: 7523331
[TBL] [Abstract][Full Text] [Related]
5. Expression of viral T-antigen in pathological tissues from transgenic mice carrying JC-SV40 chimeric DNAs.
Ressetar HG; Prakash O; Frisque RJ; Webster HD; Re RN; Stoner GL
Mol Chem Neuropathol; 1993 Sep; 20(1):59-79. PubMed ID: 8251033
[TBL] [Abstract][Full Text] [Related]
6. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.
Tavis JE; Trowbridge PW; Frisque RJ
Virology; 1994 Mar; 199(2):384-92. PubMed ID: 8122368
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody to SV40 large T-antigen labels a nuclear antigen in JC virus-transformed cells and in progressive multifocal leukoencephalopathy (PML) brain infected with JC virus.
Stoner GL; Ryschkewitsch CF; Walker DL; Soffer D; Webster HD
J Neuroimmunol; 1988 Mar; 17(4):331-45. PubMed ID: 2828425
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical elements within the JC virus DNA replication origin.
Lynch KJ; Frisque RJ
J Virol; 1990 Dec; 64(12):5812-22. PubMed ID: 2173768
[TBL] [Abstract][Full Text] [Related]
9. Interspecies-, species- and type-specific T antigenic determinants of human papovaviruses (JC and BK) and of Simian virus 40.
Beth E; Cikes M; Schloen L; di Mayorca G; Giraldo G
Int J Cancer; 1977 Oct; 20(4):551-9. PubMed ID: 72046
[TBL] [Abstract][Full Text] [Related]
10. JC virus-simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: identification of regions restricting transformation by JC virus.
Haggerty S; Walker DL; Frisque RJ
J Virol; 1989 May; 63(5):2180-90. PubMed ID: 2539511
[TBL] [Abstract][Full Text] [Related]
11. Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.
Randhawa P; Viscidi R; Carter JJ; Galloway DA; Culp TD; Huang C; Ramaswami B; Christensen ND
J Gen Virol; 2009 Mar; 90(Pt 3):634-639. PubMed ID: 19218208
[TBL] [Abstract][Full Text] [Related]
12. Characterization and application of polyclonal antibodies that specifically recognize JC virus large T antigen.
Sunden Y; Suzuki T; Orba Y; Umemura T; Asamoto M; Nagashima K; Tanaka S; Sawa H
Acta Neuropathol; 2006 Apr; 111(4):379-87. PubMed ID: 16479389
[TBL] [Abstract][Full Text] [Related]
13. JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice.
Feigenbaum L; Hinrichs SH; Jay G
J Virol; 1992 Feb; 66(2):1176-82. PubMed ID: 1309896
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.
Schell TD; Mylin LM; Georgoff I; Teresky AK; Levine AJ; Tevethia SS
J Virol; 1999 Jul; 73(7):5981-93. PubMed ID: 10364350
[TBL] [Abstract][Full Text] [Related]
15. Isolation of a monoclonal antibody that recognizes the origin binding domain of JCV, but not SV40, large T-antigen.
Grubman SA; Shin J; Phelan PJ; Gong A; Can H; Dilworth R; Kini SK; Gagnon D; Archambault J; Meinke G; Bohm A; Jefferson DM; Bullock PA
Virology; 2016 Oct; 497():92-101. PubMed ID: 27433780
[TBL] [Abstract][Full Text] [Related]
16. Altered DNA binding and replication activities of JC virus T-antigen mutants.
Tavis JE; Frisque RJ
Virology; 1991 Jul; 183(1):239-50. PubMed ID: 1647070
[TBL] [Abstract][Full Text] [Related]
17. p53 inhibits JC virus DNA replication in vivo and interacts with JC virus large T-antigen.
Staib C; Pesch J; Gerwig R; Gerber JK; Brehm U; Stangl A; Grummt F
Virology; 1996 May; 219(1):237-46. PubMed ID: 8623534
[TBL] [Abstract][Full Text] [Related]
18. The absence of JC virus antigens in Indian children with medulloblastomas.
Vasishta RK; Pasricha N; Nath A; Sehgal S
Indian J Pathol Microbiol; 2009; 52(1):42-5. PubMed ID: 19136778
[TBL] [Abstract][Full Text] [Related]
19. In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.
Schell TD
J Virol; 2004 Feb; 78(4):1751-62. PubMed ID: 14747540
[TBL] [Abstract][Full Text] [Related]
20. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
Shearer MH; Bright RK; Kennedy RC
Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
